Earnings Feed
Start Free
Home/Insiders/MCCLUSKI STEPHEN C
MS
SEC Insider//CIK 0001188728

MCCLUSKI STEPHEN C

CIK 00011887285 companiesPITTSFORD, NY
SEC Profile

Transactions

50

Companies

5

Filings

6

CIK

0001188728

Recent Transactions

50 trades
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Award

    2025-08-12+8,306→ 31,928 total
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Award

    2024-08-13+4,937→ 23,622 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−44,000→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−10,000→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−10,000→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−18,000→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−44,000→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−5,000→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Deferred Share Unit

    2024-02-12−105,458→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−10,000→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−19,597→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Restricted Stock Unit

    2024-02-12−13,090→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−18,000→ 0 total
  • Disposition to Issuer
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2024-02-12−50,000→ 0 total
  • Exercise/Conversion
    ImmunoGen, Inc.

    Common Stock

    2023-09-13$14.70/sh+10,000→ 10,000 total
  • Exercise/Conversion
    ImmunoGen, Inc.

    Common Stock

    2023-09-13$16.05/sh−10,000→ 0 total
  • Exercise/Conversion
    ImmunoGen, Inc.

    Stock Option (Right to Buy)

    2023-09-13−10,000→ 0 total
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Awards

    2023-08-15+3,749→ 18,685 total
  • Award
    ImmunoGen, Inc.

    Restricted Stock Unit

    2023-06-14+13,090→ 13,090 total
  • Award
    ImmunoGen, Inc.

    Stock Option (right to buy)

    2023-06-14+19,597→ 19,597 total
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Awards

    2022-08-16+2,426→ 14,936 total
  • Award
    ImmunoGen, Inc.

    Stock Option (right to buy)

    2022-06-15$3.37/sh+44,000→ 44,000 total
  • Award
    ImmunoGen, Inc.

    Deferred Share Unit

    2022-06-15+15,000→ 105,458 total
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Award

    2021-08-17+2,351→ 12,510 total
  • Exercise/Conversion
    MONRO, INC.$MNRO

    Options (Right to Buy)

    2021-08-06$57.78/sh−10,000→ 0 total
  • Exercise/Conversion
    MONRO, INC.$MNRO

    Common Stock

    2021-08-06$57.78/sh+10,000→ 20,159 total
  • Sale
    MONRO, INC.$MNRO

    Common Stock

    2021-08-06$58.65/sh−10,000→ 10,159 total
  • Award
    ImmunoGen, Inc.

    Stock Option (right to buy)

    2021-06-16$6.77/sh+44,000→ 44,000 total
  • Award
    ImmunoGen, Inc.

    Deferred Share Unit

    2021-06-16+15,000→ 90,458 total
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Awards

    2020-08-18+2,575→ 10,159 total
  • Award
    ImmunoGen, Inc.

    Stock Option (right to buy)

    2020-06-17$4.56/sh+50,000→ 50,000 total
  • Award
    ImmunoGen, Inc.

    Deferred Share Unit

    2020-06-17+17,000→ 75,458 total
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Awards

    2019-08-13+1,661→ 7,584 total
  • Award
    ImmunoGen, Inc.

    Stock Option (right to buy)

    2019-06-20$2.10/sh+18,000→ 18,000 total
  • Award
    ImmunoGen, Inc.

    Deferred Share Unit

    2019-06-20+4,000→ 58,458 total
  • Sale
    MONRO, INC.$MNRO

    Common Stock

    2019-02-14$77.70/sh−4,600→ 8,023 total
  • Sale
    MONRO, INC.$MNRO

    Common Stock

    2019-02-14$78.68/sh−2,000→ 6,023 total
  • Sale
    MONRO, INC.$MNRO

    Common Stock

    2019-02-14$76.76/sh−3,300→ 12,623 total
  • Exercise/Conversion
    MONRO, INC.$MNRO

    Common Stock

    2019-02-14$51.51/sh+10,000→ 15,923 total
  • Sale
    MONRO, INC.$MNRO

    Common Stock

    2019-02-14$80.34/sh−100→ 5,923 total
  • Exercise/Conversion
    MONRO, INC.$MNRO

    Options (Right to Buy)

    2019-02-14$51.51/sh−10,000→ 0 total
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Award

    2018-08-14+1,828→ 5,923 total
  • Award
    ImmunoGen, Inc.

    Deferred Share Unit

    2018-06-20+4,000→ 54,458 total
  • Award
    ImmunoGen, Inc.

    Stock Option (right to buy)

    2018-06-20$11.21/sh+18,000→ 18,000 total
  • Sale
    MONRO, INC.$MNRO

    Common Stock

    2018-02-05$55.51/sh−10,000→ 4,095 total
  • Exercise/Conversion
    MONRO, INC.$MNRO

    Common Stock

    2018-02-05$44.46/sh+10,000→ 14,095 total
  • Exercise/Conversion
    MONRO, INC.$MNRO

    Options (Right to Buy)

    2018-02-05$44.46/sh−10,000→ 0 total
  • Award
    MONRO, INC.$MNRO

    Restricted Stock Awards

    2017-08-15+2,895→ 4,095 total
  • Purchase
    MONRO, INC.$MNRO

    Common Stock

    2017-07-25$46.45/sh+1,200→ 1,200 total
  • Award
    ImmunoGen, Inc.

    Deferred Share Unit

    2017-06-13+3,000→ 50,458 total

Companies

5

Recent Filings

6

Address

10 GRANDHILL WAY

PITTSFORD, NY, 14534

View on SEC.gov